Dr. Zvi Gabbay heads our Capital Markets department. Zvi possesses extensive experience in Israel and in the United States, representing corporations and individuals in various aspects of their operations, mainly in the areas of financial regulation, securities, capital markets and international litigation.
Over more than 18 years of practice in the fields of financial regulations and enforcement, Dr. Zvi Gabbay attained an esteemed reputation for representing clients before the regulatory authorities on matters pertaining to securities laws and financial regulation, for providing ongoing legal advice to private clients and to leading corporations in relation to their capital market and corporate governance needs, as well as for representing clients before various enforcement agencies during administrative inquiries and investigations.
He specializes in securities law and in advising public companies, banks, investment houses and financial entities in relation to their activities in the global arena.
Zvi also represents clients before the regulatory authorities on matters pertaining to securities laws and financial regulation, and provides ongoing legal advice to individuals and leading corporations in relation to their capital market and corporate governance needs. He also represents clients in securities-related enforcement proceedings, including criminal and administrative inquiries and investigations.
Zvi’s vast experience includes roles as Head of Enforcement and member of the management of the Israel Securities Authority, as a lawyer in the New York office of Skadden, Arps, Slate, Meagher & Flom, and as a prosecutor in the Tel-Aviv District Attorney’s office.
As an expert in the financial regulation field, Zvi is often interviewed by leading media outlets. He also frequently publishes op-eds on emerging trends and legal developments in this area.
The Chamber’s Fintech guide for 2020 ranked Zvi as an expert in the field of Fintech. The guide describes Dr. Zvi Gabbay as “one of, if not the, go-to person on matters of regulation: he tops my list in hardcore regulatory matters”.
JSD, Columbia University, New York, 2006
LL.M, summa cum laude, Columbia University, New York, 2004
LL.M, magna cum laude, in commercial law, Bar-Ilan University, Ramat-Gan, 2002
LL.B, Hebrew University, Jerusalem, 1999
Member of Israel Bar Association since 1999
Member of New York Bar Association since 2005
News and updates - Zvi Gabbay:
Webinar: Supervision and Control Procedures – How to Do It Right
As part of the ACC Compliance Forum we lead, we will host a webinar tomorrow on the supervision and control procedures within organizations. Dr. Zvi Gabbay will discuss the theoretical aspects and challenges in the field, followed by an expert panel.
Webinar: 10 Years of Administrative Enforcement in Israel
The Rina and Meir Heth Center for the Study of Competition and Regulation at the College of Management is holding a webinar with former judges and legal experts entitled “10 Years of Administrative Enforcement in Israel.” Dr. Zvi Gabbay was invited to participate in the lawyers’ panel of experts, which will examine the impact of administrative enforcement tools on violations of the law in Israel.
SPAC: A Dream Worth Half a Billion Shekels
In recent months, the IPO market has reached a boil. It seems anyone with any kind of business is dreaming about joining the Israeli stock market.
Lets look at the figures. From 2008 (the outbreak of the subprime crisis) through 2019, 76 new companies entered the Israeli stock market through an IPO process (an average of approximately 6.33 companies per year). In 2020 alone, 27 new companies entered the Israeli stock market, and in January 2021, seven new companies entered the Israeli stock market*.
The thing is, that this seems to be just the beginning.
In light of this wave of IPOs, the Israel Securities Authority is currently drafting rules to enable the launch of an IPO in Israel through a special purpose acquisition company (SPAC).
This is the latest superhot trend in the United States poised to “immigrate to Israel.” Under this model, a company without any business activity can launch an IPO to recruit capital in order to find a suitable business to acquire or merge with the SPAC within a predefined period.
During 2020, about 250 SPACs launched IPOs in the United States and raised approximately USD 80 billion.
The proposed outline for Israeli SPACs provides for an alternative to the "standard" prospectus route (publishing a prospectus requires a significant undertaking of time and money on the part of the issuing company, and requires such a company to devote considerable managerial attention). Rather, the SPAC may merely submit documents to the ISA and the Tel Aviv Stock Exchange (TASE).
The SPAC must acquire or merge an existing business into it within a predefined period (currently a period to probably be in the range of 18 to 24 months after the IPO date). Acquiring the business will be subject to the approval of the company's shareholders by a super majority. Insofar as the SPAC does not succeed in acquiring a business within the defined period, the invested funds will be returned to investors.
The initial capital raise required is between NIS 300 million and NIS 500 million. The entrepreneur itself is required to invest at least 10% of this sum, while its shares will be subject to a defined lock-up period, during which time it may not sell them. (It is reasonable to assume the lock-up period will be longer than the period currently applicable to "interested parties" in a new company, and that it will also continue for some time after the new business is added to the SPAC.)
As stated, the ISA and TASE are still hammering out the conditions for fundraising through SPACs. These conditions will most probably include ways to protect investments until the business is added (an escrow mechanism and/or investment rules), obligatory disclosures by the SPAC for the purposes of the IPO and until a business is added, the entrepreneur’s ability to draw a salary and/or management fee from the SPAC during the period prior to the acquisition of a business, and more. It is reasonable to assume a SPAC’s success in launching an IPO will rely, primarily, on the entrepreneur’s reputation. This may also help open a window for the entry of unicorn companies (high-tech companies valued at more than USD 1 billion) into the Israeli stock market.
Either way, this is an extremely interesting regulatory development, and one that will most probably have a real impact on the Israeli capital market.
*According to data on the TASE website.